Trial Profile
Sirolimus (Rapamune) for the treatment of anti-Hu associated paraneoplastic neurological syndromes
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Encephalomyelitis
- Focus Therapeutic Use
- 03 Nov 2015 New source identified and integrated (European Clinical Trials Database : EudraCT 2008-000793-20)